Adjuvant platinum-based chemotherapy (PBCTX) improves overall survival (OS) in women with uterine mixed Mullerian malignant tumors (MMMT)

Autor: Marilyn Huang, Brian M. Slomovitz, D. Fatemi, R. Trocola, T. A. Caputo

Publikováno v: Journal of Clinical Oncology. 26:16561-16561

16561 Background: The aim of this study was to describe clinical and pathologic characteristics of patients with MMMT of the uterus who were all treated at a single institution. In addition, we wer...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ae3f99106a613c1aabc8b374a3527ed5
https://doi.org/10.1200/jco.2008.26.15_suppl.16561

Incidence and significance of thromboembolic events (TE) in patients with gastrointestinal (GI) and non-GI malignancies on systemic cytotoxic therapy

Autor: Manish A. Shah, C. Marinela, J. Randazzo, R. Trocola, David P. Kelsen, N. Pincus, Mary Agnes Templeton, Timothy R. Asmis

Publikováno v: Journal of Clinical Oncology. 25:9049-9049

9049 Background: Although venous thromboembolic events (TE) are commonly associated with solid tumor malignancies, the precise incidence and significance of TE in cancer patients has not been well established. We previously reported a high incidence

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::374ddf162f55de4ef9a1412b357a9c3e
https://doi.org/10.1200/jco.2007.25.18_suppl.9049

Cetuximab use without chronic antihistamine premedication

Autor: John P. Timoney, R. Trocola, Vivian Park, Leonard B. Saltz, C. Peake, K. Y. Chung

Publikováno v: Journal of Clinical Oncology. 24:13521-13521

13521 Background: Cetuximab is a human-murine chimeric monoclonal antibody against EGFR with approximately a 3% reported incidence of severe (≥ grade 3) anaphylactoid reactions. The overwhelming majority of such reactions have been reported with th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4de1b6676dfd2bdc0292275927acedfc
https://doi.org/10.1200/jco.2006.24.18_suppl.13521

Self-Assembled Acid-Responsive Nanosystem for Synergistic Anti-Angiogenic/Photothermal/Ferroptosis Therapy against Esophageal Cancer.

Autor: Li X; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610044, China., Li J; Key Laboratory of Drug Targeting and Drug Delivery Systems, West China School of Pharmacy, Sichuan University, Chengdu, 610044, China., He S; Key Laboratory of Drug Targeting and Drug Delivery Systems, West China School of Pharmacy, Sichuan University, Chengdu, 610044, China., Luan S; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610044, China., Zhang H; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610044, China., Yang Y; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610044, China., Chen X; Animal Experimental Center, West China Hospital, Sichuan University, Chengdu, 610044, China., Chen Y; West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, 610044, China., Zhou J; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610044, China., Fang P; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610044, China., Xiao X; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610044, China., Liang Z; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610044, China., Zeng X; West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, 610044, China., Gao H; Key Laboratory of Drug Targeting and Drug Delivery Systems, West China School of Pharmacy, Sichuan University, Chengdu, 610044, China., Yuan Y; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, 610044, China.

Publikováno v: Advanced healthcare materials [Adv Healthc Mater] 2024 Mar; Vol. 13 (6), pp. e2302787. Date of Electronic Publication: 2023 Nov 28.